EGFR and KRAS mutations in lung carcinoma: Molecular testing by using cytology specimens
Carcinoma, Non-Small-Cell Lung
Receptor, Epidermal Growth Factor
Our findings support clinical utilization of routinely prepared cytology specimens, including EBUS, CT/US. FNAs and body fluid specimens, as a reliable source for molecular testing to detect EGFR or KRAS mutations in patients with NSCLC.